Study of PAN-90806 Eye Drops, Suspension for Neovascular AMD

Clinical trial NCT03479372 · COMPLETED

Trial details

NCT number: NCT03479372
Sponsor: PanOptica, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neovascular Age-related Macular Degeneration

Start date: 2018-04-26
Primary completion: 2019-05-27
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.